Lintopride

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameLintopride
Drug Alias Name林托必利lintopridalintopridumlintoprideSTIL-2875
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 3 (5-HT3) receptor agonistsSerotonin 4 (5-HT4) receptor agonists
TargetsSerotonin 4 (5-HT4) receptorSerotonin 3 (5-HT3) receptor
Therapy Area/IndicationsNauseaGastroesophageal Reflux
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofi
Active IndicationsN/A
Inactive IndicationsNauseaGastroesophageal Reflux

Other Information

ATC CodeN/A
Related LinksN/A